Skip to main content
SpringerLink
Log in
Book cover

Emergencies in Neurology pp 163–173Cite as

Generalized Convulsive Status Epilepticus

  • Chapter
  • First Online:

  • 697 Accesses

Abstract

Status epilepticus (SE) is a common neurological emergency associated with high morbidity and mortality [1]. SE is broadly classified based solely on the presence or absence of convulsions into convulsive SE (CSE) and nonconvulsive SE (NCSE). Early institution of appropriate treatment is associated with good outcomes.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Fountain NB. Status epilepticus: risk factors and complications. Epilepsia. 2000;41:S23–30.

    Article  Google Scholar 

  2. Chin RFM, Neville BGR, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol. 2004;11:800–10.

    Article  CAS  Google Scholar 

  3. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029–35.

    Article  CAS  Google Scholar 

  4. Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Incidence of status epilepticus in Rochester, Minnesota, 1965–1984. Neurology. 1998;50:735–41.

    Article  CAS  Google Scholar 

  5. Logroscino G, Hesdorff DC, Cascino G, Annegers JF, Hauser WA. Time trends in incidence, mortality, and case-fatality after first episode of status epilepticus. Epilepsia. 2001;42:1031–5.

    Article  CAS  Google Scholar 

  6. Coeytaux A, Jallon P, Galobardes B, Morabia A. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology. 2000;55:693–7.

    Article  CAS  Google Scholar 

  7. Knake S, Rosenow F, Vescovi M, et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia. 2001;47:714–8.

    Article  Google Scholar 

  8. Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62:1698–702.

    Article  Google Scholar 

  9. Al-Mufti F, Claassen J. Neurocritical care—status epilepticus review. Crit Care Clin. 2014;30:751–64.

    Article  Google Scholar 

  10. Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus—report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56:1515–23.

    Article  Google Scholar 

  11. Kapur J, Macdonald RL. Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci. 1997;17:7532–40.

    Article  CAS  Google Scholar 

  12. Jones DM, Esmaeil N, Maren S, Macdonald RL. Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. Epilepsy Res. 2002;50:301–12.

    Article  CAS  Google Scholar 

  13. DeLorenzo RJ, Waterhouse EJ, Chum F, et al. Persistent nonconvulsive status epilepticus after control of convulsive status epilepticus. Epilepsia. 1998;39:833–40.

    Article  CAS  Google Scholar 

  14. Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3–23.

    Article  Google Scholar 

  15. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51:676–85.

    Article  Google Scholar 

  16. Foreman B, Hirsch LJ. Epilepsy emergencies: diagnosis and management. Neurol Clin. 2012;30:11–41.

    Article  Google Scholar 

  17. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol. 1995;12:316–25.

    Article  CAS  Google Scholar 

  18. Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993;43:483–8.

    Article  CAS  Google Scholar 

  19. Garzon E, Fernandez RM, Sakamoto AC. Analysis of clinical characteristics and risk factors for mortality in human status epilepticus. Seizure. 2003;12:337–45.

    Article  Google Scholar 

  20. Misra UK, Kalita J, Patel R. Sodium valproate vs. phenytoin in status epilepticus: a pilot study. Neurology. 2006;67:340–2.

    Article  CAS  Google Scholar 

  21. Murthy JMK, Jayalaxmi SS, Kanikannan MA. Convulsive status epilepticus: clinical profile in a developing country. Epilepsia. 2007;48:2217–23.

    PubMed  Google Scholar 

  22. Shorvon S. Definition, classification and frequency of status epilepticus. In: Shorvon S, editor. Status epilepticus, its clinical features and treatment in children and adults. Cambridge: Cambridge University Press; 1994. p. 21–30.

    Chapter  Google Scholar 

  23. Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134:2802–18.

    Article  Google Scholar 

  24. Trinka E, Hofler J, Leitinger M, Brigo F. Pharmacotherapy for status epilepticus. Drugs. 2015;75:1499–521.

    Article  CAS  Google Scholar 

  25. Silbergleit R, Durkalshki V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366:591–600.

    Article  CAS  Google Scholar 

  26. Trinka E, Kalviainen R. 25 years of advances in definition, classification and treatment of status epilepticus. Seizure. 2017;44:65–73. https://doi.org/10.1016/j.seizure.2016.11.001.

    Article  PubMed  Google Scholar 

  27. Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure. 2014;23:167–74.

    Article  Google Scholar 

  28. Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011;10:922–30.

    Article  Google Scholar 

  29. Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry. 2005;76:534–9.

    Article  CAS  Google Scholar 

  30. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59:205–10.

    Article  Google Scholar 

  31. Garzon E, Fernandez RM, Sakamoto AC. Analysis of clinical characteristics and risk factors for mortality in human status epilepticus. Seizure. 2003;12:337–45.

    Article  Google Scholar 

  32. Herman ST, Abend NS, Bleck TP, et al. Consensus statement on continuous EEG in critically ill adults and children, Part I: indications. J Clin Neurophysiol. 2015;32:87–95.

    Article  Google Scholar 

  33. Meldrum BS. Excitotoxicity and epileptic brain damage. Epilepsy Res. 1991;10:55–61.

    Article  CAS  Google Scholar 

  34. Kapur J, Macdonald RL. Rapid seizure-induced reduction of benzodiazepine and Zn21 sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci. 1997;17:7532–40.

    Article  CAS  Google Scholar 

  35. Rossetti AO. Which anesthetic should be used in the treatment of refractory status epilepticus? Epilepsia. 2007;48(Suppl 8):52–5.

    Article  Google Scholar 

  36. Claassen J, Hirsch LJ, Emerson RC, et al. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43:146–53.18.

    Article  CAS  Google Scholar 

  37. Horn P, Oddo M, Schmitt SE. Electroencephalography. In: Le Roux DP, Levine MJ, Kofke WR, editors. Monitoring in neurocritical care. Philadelphia: Elsevier Sunders; 2014. p. 246–56.

    Google Scholar 

  38. Kowalski RC, Ziai WC, Rees RN, et al. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med. 2012;40:2677–84.

    Article  CAS  Google Scholar 

  39. Sutter R, Marsh S, Fuhr P, Kaplan PW, Ruegg S. Anesthetic drugs in status epilepticus—risk or rescue? A six-year cohort study. Neurology. 2013;82:656–64.

    Article  Google Scholar 

  40. Marchi NA, Novy J, Faouzi M, Stahli C, Burnand B, Rossetti AO. Status epilepticus: impact of therapeutic coma on outcome. Crit Care Med. 2015;43:1003–9.

    Article  Google Scholar 

  41. Sutter R, Kaplan PE. Can anesthetic treatment worsen outcome in status epilepticus? Epilepsy Behav. 2015;49:294–7.

    Article  Google Scholar 

  42. Alvarez V, Lee JW, Westover MB, et al. Therapeutic coma for status epilepticus: differing practices in a prospective multicenter study. Neurology. 2016;87:1650–9.

    Article  CAS  Google Scholar 

  43. Cuero MR, Varelas PN. Super-refractory status epilepticus. Curr Neurol Neurosci Rep. 2015;15:74.

    Article  Google Scholar 

  44. Tian L, Li Y, Xue X, et al. Super-refractory status epilepticus in West China. Acta Neurol Scand. 2015;132:1–6.

    Article  CAS  Google Scholar 

  45. Martin B, Kapur J. A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation. Epilepsia. 2008;49:248–55.

    Article  CAS  Google Scholar 

  46. Hsieh C, Sung PS, Tsai JJ, et al. Terminating prolonged refractory status epilepticus using ketamine. Clin Neuropharmacol. 2010;33:165–7.

    Article  Google Scholar 

  47. Sabharwal V, Ramsay E, Martinez R, et al. Propofol-ketamine combination therapy for effective control of super-refractory status epilepticus. Epilepsy Behac. 2015;52:264–6.

    Article  Google Scholar 

  48. Fang Y, Wang X. Ketamine for treatment of refractory status epilepticus. Seizure. 2015;30:14–20.

    Article  Google Scholar 

  49. Borris DJ, Bertram EH, Kapur J. Ketamine controls prolonged status epilepticus. Epilepsy Res. 2000;42:117–22.

    Article  CAS  Google Scholar 

  50. Zeiler FA, Teitelbaum J, Gillman LM, West M. NMDA antagonists for refractory seizures. Neurocrit Care. 2014;20:502–13.

    Article  CAS  Google Scholar 

  51. Wusthoff CJ, Kranick SM, Morley JF, Christina Bergqvist AG. The ketogenic diet in treatment of two adults with prolonged nonconvulsive status epilepticus. Epilepsia. 2010;51:1083–5.

    Article  CAS  Google Scholar 

  52. Thakur KR, Probasco JC, Hocker SE, et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology. 2014;82:665–70.

    Article  CAS  Google Scholar 

  53. Khawaja AM, DeWolfe JL, Miller DW, Szaflarski JP. New-onset refractory status epilepticus (NORSE)—the potential role for immunotherapy. Epilepsy Behav. 2015;47:17–23.

    Article  Google Scholar 

  54. Lopinto-Khouey C, Sperling MR. Autoimmune status epilepticus. Curr Treat Options Neurol. 2013;15:545–56.

    Article  Google Scholar 

  55. Wijidicks EFM. The multifaceted care of status epilepticus. Epilepsia. 2013;54(Suppl 6):61–3.

    Article  Google Scholar 

  56. Hocker S. Systemic complications of status epilepticus—an update. Epilepsy Behav. 2015;49:83–7.

    Article  Google Scholar 

  57. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital statue epilepticus. N Engl J Med. 2001;345:631–7.

    Article  CAS  Google Scholar 

  58. Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010;51:251–6.

    Article  Google Scholar 

  59. Claassen J, Lokin JK, Fitsimmons BF, et al. Predictors of functional disability and mortality after status epilepticus. Neurology. 2002;58:139–42.

    Article  CAS  Google Scholar 

  60. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339:792–8.

    Article  CAS  Google Scholar 

  61. Kantanen AM, Reinikainen M, Parvianen L, et al. Incidence and mortality of super-refractory status epilepticus in adults. Epilepsy Behav. 2015;49:131–4.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, CARE Institute of Neurosciences, CARE Outpatient Centre, CARE Hospitals, Hyderabad, Telangana, India

    J. M. K. Murthy

Authors
  1. J. M. K. Murthy
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, All India Institute of Medical Sciences, New Delhi, India

    Mamta Bhushan Singh

  2. Department of Neurology, All India Institute of Medical Sciences, New Delhi, India

    Rohit Bhatia

Rights and permissions

Reprints and permissions

Copyright information

© 2019 The Author(s)

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Murthy, J.M.K. (2019). Generalized Convulsive Status Epilepticus. In: Singh, M., Bhatia, R. (eds) Emergencies in Neurology . Springer, Singapore. https://doi.org/10.1007/978-981-13-5866-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-5866-1_8

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-5864-7

  • Online ISBN: 978-981-13-5866-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation